Navigation Links
A Fresh Alternative to Painful Chemotherapy Developed in UK

Chemotherapy is a standard regimen in most cancer treatments. Since it is a very painful process, continuous attempts are made to replace it with something more comfortable for the patient.

Now researchers say that LHRH agonists like the drug Zoladex switch off the ovary and stop the production of a female hormone that encourages some tumours to grow.

An agonist achieves a normal action, often mimicking the action of a naturally occurring substance.

Luteinizing hormone-releasing hormone is a naturally occurring hormone that controls sex hormones in both men and women. Thus, an LHRH agonist serves in a manner similar to LHRH to control the same sex hormones.

Four London centres found that even when used alone, the chemical worked as well as conventional chemotherapy in some cases, the Lancet journal said.

Breast cancer charities say that younger women might benefit the most.

Many types of breast cancer are sensitive to hormones produced naturally by a woman, including the sex hormone oestrogen, and can grow faster if a woman is producing them. The London researchers, from the Cancer Research UK Centre for Epidemiology, the Wolfson Institute for Preventive Medicine, and Queen Mary's School of Medicine and Dentistry, combined the results of 16 other research projects into LHRH agonists and breast cancer.

When all the different results are added together, the overall findings offer a more reliable indicator as to how well the treatment works.

They found that pre-menopausal women given LHRH agonists did as well as those given standard chemotherapy.

When the two treatments were given together, the women did even better - with cancer 13% less likely to come back.

As expected, LHRH agonists were effective only where a tumour was proven to be sensitive to oestrogen.

The study authors said that the results proved th at this was an additional, effective class of drugs in the fight against breast cancer.

Dr Sarah Cant, from Breakthrough Breast Cancer, said that additional research was now needed to see how the drug worked with the most up-to-date types of cancer chemotherapy.

Maria Leadbeater, Clinical Nurse Specialist at Breast Cancer Care, said that the drugs would be particularly useful to younger patients who faced losing their fertility with conventional chemotherapy.


'"/>




Related medicine news :

1. Fresh approach to TB treatment
2. Fresh warnings to doctors regarding abortion pill
3. Fresh Cases of Bird-Flu Prepares the Ground for More Chicken Martyrs
4. Fresh Bird Flu Cases Spotted In Southern Russia
5. Pakistan Scared By Fresh Bird Flu Case
6. Fresh Polio Cases Reported In Uttar Pradesh
7. Nothing Can Equate Fresh Vegetables and Fruits
8. Fresh Outbreak Of Bird Flu In Nigeria
9. Foreign Fresher Students Offered Scholarship By Fudan
10. Fresh bird flu vaccines made in China
11. Freshness Dating? Researchers Express Doubts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... April 29, 2016 , ... ... flexibility in repaying their loans, more information about their loan terms and accounts, ... outstanding student loan debt, including federal and private loans, has reached $1.3 trillion, ...
(Date:4/29/2016)... ... 29, 2016 , ... Spine Team Texas, a comprehensive spine physician group specializing ... their physicians has been invited to be a featured speaker at the Texas Society ... on April 30, 2016. , Dr. R. Scott McPherson, a physical medicine and ...
(Date:4/29/2016)... ... April 29, 2016 , ... The ... (CCA), is pleased to announce the launch of the GFCP Scoop ... and more. The purpose of the GFCP Scoop site is to ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... , ... Regenerative Medicine Solutions (RMS) scored 94.8124 out of 100 ... second place for Tampa’s Best Places to Work. They were ranked in the Big ... accomplishment for our team,” says RMS Human Resources Manager Irene Miller. “We work hard ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase of ... and an increase of 1.2% on an adjusted pro forma, ... quarter were $0.52 reported, a decrease of 47.5% from the ... over the prior year period , The Company increases ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ...
(Date:4/28/2016)... Oramed Pharmaceuticals Inc. (NASDAQ: ... on the development of oral drug delivery systems, announced today ... conference, presented by Joseph Gunnar & Co. LLC, ... York . Nadav Kidron , CEO of Oramed, ... Presentation Details:   PIONEERS 2016, presented by ...
Breaking Medicine Technology: